Atherosclerosis
Volume 194, Issue 2 , Pages 465-472 , October 2007

Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: The effect of improved glycemic control

  • Chaiyasit Sittiwet

      Affiliations

    • Department of Medicine, Division of Internal Medicine, University of Helsinki, Helsinki, Finland
    • Department of Chemistry, Faculty of Sciences, Mahasarakham University, Mahasarakham, Thailand
    • Current address: Department of Biochemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
    • ,
  • Helena Gylling

      Affiliations

    • Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
    • ,
  • Maarit Hallikainen

      Affiliations

    • Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
    • ,
  • Jussi Pihlajamäki

      Affiliations

    • Department of Medicine, University of Kuopio, Kuopio, Finland
    • ,
  • Leena Moilanen

      Affiliations

    • Department of Medicine, University of Kuopio, Kuopio, Finland
    • ,
  • David E. Laaksonen

      Affiliations

    • Department of Medicine, University of Kuopio, Kuopio, Finland
    • Department of Physiology, University of Kuopio, Kuopio, Finland
    • ,
  • Leo Niskanen

      Affiliations

    • Department of Medicine, University of Kuopio, Kuopio, Finland
    • ,
  • Jyrki J. Ågren

      Affiliations

    • Department of Physiology, University of Kuopio, Kuopio, Finland
    • ,
  • Markku Laakso

      Affiliations

    • Department of Medicine, University of Kuopio, Kuopio, Finland
    • ,
  • Tatu A. Miettinen

      Affiliations

    • Department of Medicine, Division of Internal Medicine, University of Helsinki, Helsinki, Finland
    • Corresponding Author InformationCorresponding author at: Biomedicum Helsinki C 4 22, P.O. Box 700, FIN-00029 HUS, Finland. Tel.: +358 9 4717 1852; fax: +358 9 47171851.

Received 9 June 2006 ,Revised 15 August 2006 ,Accepted 23 August 2006.

References 

  1. Dahl-Jørgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?. Diabetologia. 2005;48:1445–1453
  2. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care. 2006;29:798–804
  3. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care. 2002;25:43–48
  4. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care. 2003;26:2194–2197
  5. Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003;26:1374–1379
  6. Maahs DM, Maniatis AK, Nadeau K, Wadwa RP, McFann K, Klingensmith GJ. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr. 2005;147:544–546
  7. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987;28:613–628
  8. Rivellese A, Riccardi G, Romano G, et al. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation. Diabetologia. 1988;31:884–888
  9. Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Arrol S, Mackness M. Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus. Arterioscler Thromb. 1992;12:920–928
  10. Pérez A, Caixàs A, Carreras G, et al. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control. Diabetes Res Clin Pract. 1997;36:83–90
  11. Andersen E, Hellström P, Hellström K. Cholesterol and bile acid metabolism in middle-aged diabetics. Diabete Metab. 1986;12:261–267
  12. Gylling H, Miettinen TA. Cholesterol absorption and cholesterol and bile acid synthesis in two brothers with IDDM and diarrhoea. Diabetes Care. 1994;17:1345–1347
  13. Kojima H, Hidaka H, Matsumura K, et al. Effect of glycemic control on plasma plant sterol levels and post-heparin diamine oxidase activity in type 1 diabetic patients. Atherosclerosis. 1999;145:389–397
  14. Miettinen TA, Gylling H, Tuominen J, Simonen P, Koivisto V. Low synthesis and high absorption of cholesterol characterize type 1 diabetes. Diabetes Care. 2004;27:53–58
  15. Gylling H, Tuominen JA, Koivisto VA, Miettinen TA. Cholesterol metabolism in type 1 diabetes. Diabetes. 2004;53:2217–2222
  16. Järvisalo M, Raitakari O, Gylling H, Miettinen TA. Cholesterol absorption and synthesis in children with type 1 diabetes. Diabetes Care, in press.
  17. Miettinen TA. Detection of changes in human cholesterol metabolism. Ann Clin Res. 1970;2:300–320
  18. Gylling H, Miettinen TA. Serum noncholesterol sterols related to cholesterol metabolism in familial hypercholesterolemia. Clin Chim Acta. 1988;178:41–50
  19. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20–31
  20. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism. 1989;38:136–140
  21. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345–1353
  22. Miettinen TA. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res. 1988;29:43–51
  23. Miettinen TA, Gylling H. Cholesterol absorption efficiency with sterol metabolism in obesity. Atherosclerosis. 2000;153:241–248
  24. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr. 2000;72:82–88
  25. Simonen PP, Gylling HK, Miettinen TA. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care. 2002;25:1511–1515
  26. Simonen PP, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetes. Obes Res. 2002;10:328–335
  27. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res. 2003;45:507–512
  28. Bloks VW, Bakker-Van Waarde WM, Verkade HJ, et al. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia. 2004;47:104–112
  29. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism. 1991;40:842–848
  30. Gylling H, Miettinen TA. Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus without and with coronary artery disease. Atherosclerosis. 1996;126:325–332
  31. Sutherland WHF, Williams MJA, Nye ER, Restieaux NJ, de Jong SA, Walker HL. Associations of plasma noncholesterol sterol levels with severity of coronary artery disease. Nutr Metab Cardiovasc Dis. 1998;8:386–391
  32. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol. 2000;35:1185–1191
  33. Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 2002;51:1519–1521
  34. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis. 2006;16:13–21
  35. Rajaratnam RA, Gylling H, Miettinen TA. Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21:1650–1655
  36. Miettinen TA, Gylling H, Strandberg T, Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S investigators. BMJ. 1998;316:1127–1130
  37. Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 2001;104:3046–3051
  38. Ketomäki A, Gylling H, Siimes MA, Vuorio A, Miettinen TA. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia. Pediatr Res. 2003;53:648–653
  39. Miettinen TA. Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions. Ann Clin Res. 1971;3:264–271
  40. Koivisto PVI, Miettinen TA. Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion. Lipids. 1988;23:993–996
  41. Strandberg TE, Tilvis RS, Miettinen TA. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J Lipid Res. 1990;31:1637–1643
  42. Simonen PP, Gylling H, Miettinen TA. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes. Atherosclerosis 2006, in press.

PII: S0021-9150(06)00530-2

doi: 10.1016/j.atherosclerosis.2006.08.044

Atherosclerosis
Volume 194, Issue 2 , Pages 465-472 , October 2007

Article Tools

* Image Usage & Resolution